Budesonide MMX versus budesonide tablets for microscopic colitis
Part of Digestive system clinical trials.
This Phase 2 trial compares two forms of the same medicine, budesonide, to see which one works better and is safer for bringing microscopic colitis symptoms under control. If you have active watery/loose diarrhea and confirmed microscopic colitis, you may be offered one of these treatments to induce remission.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18–80, and able to join all study visits and procedures
- Have active microscopic colitis symptoms (watery/loose, not bloody) for at least 12 weeks if newly diagnosed, or a relapse for at least 1 week if you have had it before
- Have recent colon exam (colonoscopy or flexible sigmoidoscopy) showing microscopic colitis on biopsy (either lymphocytic or collagenous type)
- In the last 8 weeks, avoid many other diarrhea- or bowel-related medicines, including steroids (except budesonide), immune medicines, bismuth, and antibiotics (except up to 7 days for other reasons)
- If you can become pregnant: use reliable birth control and have a negative urine pregnancy test before starting; do not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication (SAR444336) can help adults with microscopic colitis stay in remission longer. It may be an option if you are already taking budesonide and have had flares in the past 8 months.
This trial tests whether an oral antibiotic called rifaximin can improve symptoms during a microscopic colitis flare. It aims to see if it is safe and effective for people whose colitis was confirmed by colon biopsy.
This trial studies whether budesonide extended-release tablets are safe and effective for improving symptoms in children ages 5–17 with active, mild to moderate ulcerative colitis. It also measures how the medicine moves through the body.
This trial studies whether combining a specific diet with an oral steroid called budesonide can calm symptoms in people with mild to moderate ulcerative colitis. It may help reduce inflammation in the colon while building on stable current treatments.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
This trial tests different doses of budesonide rectal foam in children and teens (ages 5–17) with active, mild-to-moderate ulcerative colitis limited to the rectum and lowest part of the colon. It looks at safety, how well it works, and how the medicine moves through the body.
Hear when a new Microscopic Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.